BEAUTYFARM MED (02373) · Company profile · Eqvero

BEAUTYFARM MED

02373HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	3 bn CNY	2.57 bn CNY	2.15 bn CNY	1.64 bn CNY	1.78 bn CNY
Cost of revenue	1.12 bn CNY	999.63 m CNY	836.23 m CNY	620.33 m CNY	671.77 m CNY
Research and development expense	41.94 m CNY	36.03 m CNY	34.07 m CNY	31.19 m CNY	18.03 m CNY
Selling, general and administrative expense	991.66 m CNY	849.84 m CNY	696.52 m CNY	575.38 m CNY	571.91 m CNY
Operating profit after depreciation	451.78 m CNY	309.25 m CNY	268.99 m CNY	135.55 m CNY	257.49 m CNY
Operating profit before depreciation	856.53 m CNY	691.83 m CNY	600.72 m CNY	432.8 m CNY	532.68 m CNY
EBIT	451.78 m CNY	309.25 m CNY	268.99 m CNY	135.55 m CNY	257.49 m CNY
EBITDA	856.53 m CNY	691.83 m CNY	600.72 m CNY	432.8 m CNY	532.68 m CNY
Interest expense	32.16 m CNY	27.56 m CNY	24.81 m CNY	24.71 m CNY	24.22 m CNY
Profit before tax	450.07 m CNY	317.88 m CNY	288.27 m CNY	130.48 m CNY	255.1 m CNY
Income tax expense	109.79 m CNY	65.41 m CNY	58.13 m CNY	19.94 m CNY	46.76 m CNY
Income before extraordinary items	317.56 m CNY	228.46 m CNY	215.66 m CNY	103.11 m CNY	193.48 m CNY
Common dividends	159.13 m CNY	113.18 m CNY	100.51 m CNY	80.47 m CNY	—
Total dividends	159.13 m CNY	113.18 m CNY	100.51 m CNY	80.47 m CNY	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.